A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to individuals administering substances of uncertain source.
Several experts stated the demand for retatrutide could be connected to the rising price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking penalties, legal action or prison.
Service Reaction and Material Removal
Based on the social media company, the platform has taken down problematic content and banned associated keywords and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or administering at residence.
Within minutes of joining one community, a vendor posted contact information, where the majority of purchases take place. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Information and Pricing
Within these groups, messages display dark colored packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.
